Explainer
Type 2 diabetes explained: diagnosis, treatment and prevention
Type 2 diabetes is the most common form of diabetes: blood glucose runs too high because the body does not make enough insulin or does not use it well.[1] About 90% to 95% of the more than 40 million Americans with diabetes have type 2.[2] The American Diabetes Association diagnoses diabetes at an A1C of 6.5% or higher or a fasting glucose of 126 mg/dL or higher.[3][4] In the Diabetes Prevention Program trial, a lifestyle programme cut new cases by 58% compared with placebo in people at high risk.[5]
Type 2 diabetes is a condition in which blood glucose is too high.[1] It affects tens of millions of people in the US.[6] In a large trial of people at high risk, a lifestyle programme and metformin both reduced new cases.[5] This page covers what the disease is, how it is diagnosed, how common it is, the main treatments, and what the best-known prevention trial found.
This page is general information, not medical advice. Talk to a clinician about testing, your results and any treatment. It describes medicine types but gives no doses. Prevention figures come from a randomised controlled trial (the DPP) and its follow-up study; treatment descriptions come from NIDDK and NHS guidance.
What type 2 diabetes is
Your body turns food into glucose, a sugar that cells use for energy. Insulin is a hormone made by the pancreas, and it helps glucose get into your cells. In type 2 diabetes, the body does not make enough insulin or does not respond to it well, so glucose builds up in the blood instead of reaching the cells.[1][7]
Type 2 diabetes combines insufficient insulin secretion with reduced insulin action, leaving excess glucose in the circulation rather than in tissues.[1][7] The gut hormone GLP-1 is part of normal glucose control: it boosts insulin secretion, suppresses glucagon, slows gastric emptying and reduces food intake.[8] GLP-1 receptor agonists, one class of diabetes medicine, act on the same receptor; NIDDK says they keep glucose from rising too high after eating.[9]
Type 2 diabetes is more likely in people who are 45 or older, have a family history of diabetes, are overweight or have obesity, or are physically inactive. It is also more likely in people with prediabetes or a history of gestational diabetes.[10] The CDC says more children, teens and young adults are developing it than in the past.[11]
Symptoms often build slowly over several years and can be so mild that they go unnoticed. Many people have none.[12] Some only find out when a related problem appears, such as blurred vision or heart disease. Diabetes is also linked to sleep apnea, depression, some cancers and dementia.[13]
How common it is
The CDC estimates that 40.1 million people in the US, 12.0% of the population, had diabetes in 2023. About 27.6% of adults with diabetes, roughly 11.0 million people, did not know they had it.[6] About 90% to 95% of people with diabetes have type 2.[2] The CDC also estimates that 115.2 million US adults have prediabetes, meaning glucose is raised but below the diabetes range.[14]
How it is diagnosed
Diagnosis uses blood tests. The American Diabetes Association (ADA) lists these cut-offs:
| Test | Normal | Prediabetes | Diabetes |
|---|---|---|---|
| A1C (average glucose over 2–3 months) | Below 5.7% | 5.7% to 6.4% | 6.5% or higher[3] |
| Fasting plasma glucose (after 8+ hours) | Below 100 mg/dL | 100–125 mg/dL | 126 mg/dL or higher[4] |
| 2-hour oral glucose tolerance test | Below 140 mg/dL | 140–199 mg/dL | 200 mg/dL or higher[15] |
A random glucose of 200 mg/dL or higher in someone with severe symptoms also counts as diabetes.[15] A diagnosis usually needs a test repeated on a second day, done in a healthcare setting.[16] Home glucose meters cannot diagnose diabetes.[17] Citing the ADA’s Standards of Care, NIDDK says people with normal results should be retested every 3 years, and people with prediabetes every year.[18]
Treatment: lifestyle and medicine classes
NIDDK says managing blood glucose, blood pressure and cholesterol, quitting smoking, healthy meals, cutting calories where needed and staying active are important parts of managing type 2 diabetes, along with any prescribed medicines.[19] The NHS says lifestyle changes can sometimes return glucose to normal and put diabetes into remission.[20]
The main medicine classes, as described by NIDDK and the NHS:
- Metformin. Most people start with it. It makes the liver release less glucose and helps the body use insulin better.[21]
- SGLT2 inhibitors. These lower blood sugar by letting extra sugar leave the body in urine. The NHS usually offers them alongside metformin.[22]
- GLP-1 receptor agonists. These are injected medicines that stop glucose rising too high after meals. They may reduce hunger and help some weight loss, but they do not replace insulin.[9] The NHS says one may be added for people with a history of heart disease, or for people living with obesity when other treatments cannot lower blood sugar.[23] In September 2025 the WHO added GLP-1 therapies to its Essential Medicines List for type 2 diabetes in high-risk groups.[24] Examples include semaglutide and tirzepatide; the GLP-1 explainer covers how they work.
- Insulin. NIDDK says people may need more than one medicine over time, which can include insulin.[25]
Some GLP-1 drugs also have outcome evidence beyond glucose. In the randomised FLOW trial of 3,533 people with type 2 diabetes and kidney disease, semaglutide cut the risk of major kidney events or kidney- or heart-related death by 24%.[26] In August 2026, Lilly announced FDA approval of tirzepatide to lower the risk of major cardiovascular events in high-risk adults with type 2 diabetes.[27] More trials are covered in the GLP-1 outcome trials explainer and the metabolic medicine crash course.
For some people with obesity, weight-loss (metabolic) surgery can bring glucose back to a healthy range, and some no longer need diabetes medicines afterwards.[28]
What the Diabetes Prevention Program showed
The Diabetes Prevention Program (DPP) was a randomised controlled trial run at 27 US centres from 1996 to 2001.[29] It enrolled 3,234 adults without diabetes but with raised glucose. They were given placebo, metformin, or a lifestyle programme aiming for at least 7% weight loss and 150 minutes of activity a week.[29]
After an average of 2.8 years, the lifestyle programme had cut new cases of diabetes by 58% and metformin by 31%, compared with placebo.[5] Put another way, 6.9 people needed to follow the lifestyle programme, or 13.9 to take metformin, to prevent one case over three years.[30] The lifestyle programme cut risk by 71% in people aged 60 and older.[31]
Follow-up in the DPP Outcomes Study found the effect lasted at least 15 years, but shrank: the lifestyle group’s diabetes rate was 27% lower than placebo at that point.[32] NIDDK now says people at risk may prevent or delay type 2 diabetes by losing 5% to 7% of their weight and being active at least 30 minutes on 5 days a week.[33] A group version of the programme is offered through the CDC’s National Diabetes Prevention Program, which Medicare began covering in 2018.[34]
Read the GLP-1 explainer next for how the newer drugs work, then the obesity explainer for the related weight question.
Read next
Next in the crash course
Intermittent fasting explained: 16:8, 5:2 and what trials show
What intermittent fasting and time-restricted eating are, what randomised trials show for weight and cholesterol, and how to read the scary headlines.
More in GLP-1 and metabolic medicine
Questions readers ask
What A1C level means diabetes?
The American Diabetes Association lists an A1C below 5.7% as normal, 5.7% to 6.4% as prediabetes and 6.5% or higher as diabetes. The test reflects average blood glucose over the past two to three months.[3]
What fasting blood sugar means diabetes?
A fasting plasma glucose of 126 mg/dL or higher is in the diabetes range, and 100 to 125 mg/dL is prediabetes, according to the American Diabetes Association.[4]
Can a home glucose meter diagnose diabetes?
No. NIDDK says over-the-counter blood glucose meters cannot diagnose diabetes. The ADA says a diagnosis usually needs a test repeated on a second day in a healthcare setting.[17][16]
How many Americans have diabetes?
The CDC estimates that 40.1 million people in the US, 12.0% of the population, had diabetes in 2023, including about 11.0 million adults who did not know it. It estimates that 115.2 million adults have prediabetes.[6][14]
Are GLP-1 drugs used for type 2 diabetes?
Yes. The NHS says people with type 2 diabetes and a history of heart disease may be offered a GLP-1 agonist, usually injected once a week. NIDDK says these drugs are not substitutes for insulin.[23][9]
Can type 2 diabetes be prevented?
It can be delayed or prevented in some people at high risk. In the Diabetes Prevention Program, a lifestyle programme aiming for at least 7% weight loss and 150 minutes of activity a week cut new cases by 58% over an average 2.8 years compared with placebo, and metformin cut them by 31%.[29][5][32]
Can type 2 diabetes go into remission?
The NHS says lifestyle changes can sometimes lower blood glucose to a normal level and stop diabetes, which is called remission.[20]
Sources
· 34 claims from 9 publishers
Each numbered claim is a statement we checked against the sources listed with it. Tap a number in the text to see its sources in place.
- [1]
The NIH's diabetes institute (NIDDK) describes type 2 diabetes as the most common type of diabetes, a disease in which blood glucose is too high because the body does not make enough insulin or does not use insulin well. confirmedas of 2026-11-07
- Type 2 Diabetes · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · What is type 2 diabetes? (retrieved 2026-11-07)
- Type 2 Diabetes · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · What is type 2 diabetes? (retrieved 2026-11-07)
- [3]
The American Diabetes Association lists an A1C below 5.7% as normal, 5.7% to 6.4% as prediabetes and 6.5% or higher as diabetes; the A1C test reflects average blood glucose over the past two to three months and needs no fasting. confirmedas of 2026-11-07
- Diagnosis · American Diabetes Association · Primary source · What is the A1C test and what does it show? (retrieved 2026-11-07)
- Diagnosis · American Diabetes Association · Primary source · A1C result table (retrieved 2026-11-07)
- Diagnosis · American Diabetes Association · Primary source · What is the A1C test and what does it show? (retrieved 2026-11-07)
- [4]
The American Diabetes Association lists a fasting plasma glucose below 100 mg/dL as normal, 100 to 125 mg/dL as prediabetes and 126 mg/dL or higher as diabetes, after at least 8 hours without food or drink other than water. confirmedas of 2026-11-07
- [5]
Over an average 2.8 years of follow-up, the DPP lifestyle programme reduced the incidence of type 2 diabetes by 58% and metformin by 31% compared with placebo, and the lifestyle programme was significantly more effective than metformin. confirmedas of 2026-11-07
- Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin (NEJM 2002; PubMed abstract) · New England Journal of Medicine (via NCBI PubMed) · Primary source · 2002-02-07 · Abstract, Results (retrieved 2026-11-07)
- Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin (NEJM 2002; PubMed abstract) · New England Journal of Medicine (via NCBI PubMed) · Primary source · 2002-02-07 · Abstract, Results (retrieved 2026-11-07)
- [6]
The CDC's National Diabetes Statistics Report estimates that 40.1 million people in the US, 12.0% of the population, had diagnosed or undiagnosed diabetes in 2023, and that 27.6% of adults with diabetes, about 11.0 million people, were undiagnosed. confirmedas of 2026-09-16
- National Diabetes Statistics Report · Centers for Disease Control and Prevention · Primary source · Key figures: 40.1 million, 12.0%; undiagnosed 27.6% (11.0 million). Cached by fetch-source 2026-11-07; page reviewed September 16, 2026 (retrieved 2026-11-07)
- National Diabetes Statistics Report · Centers for Disease Control and Prevention · Primary source · Key figures (27.6% undiagnosed) (retrieved 2026-11-07)
- [7]
Insulin, a hormone made by the pancreas, helps glucose get into cells to be used for energy; in type 2 diabetes too much glucose stays in the blood and not enough reaches the cells. confirmedas of 2026-11-07
- Type 2 Diabetes · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · What is type 2 diabetes? (retrieved 2026-11-07)
- Type 2 Diabetes · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · What is type 2 diabetes? (sentence begins "Insulin, a hormone made by the pancreas") (retrieved 2026-11-07)
- [8]
GLP-1 is a hormone released from gut enteroendocrine cells that augments insulin secretion, inhibits glucagon secretion, slows gastric emptying and reduces food intake. confirmedas of 2026-10-10
- Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1 (Cell Metabolism review) · Cell Metabolism (Cell Press) · Primary source · 2018-04-01 · Abstract (retrieved 2026-10-10)
- [9]
NIDDK says GLP-1 receptor agonists keep blood glucose from rising too high after eating, may reduce hunger and help some weight loss, and are not substitutes for insulin. confirmedas of 2026-11-07
- Insulin, Medicines, & Other Diabetes Treatments · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · Other injected medicines (retrieved 2026-11-07)
- Insulin, Medicines, & Other Diabetes Treatments · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · Other injected medicines (retrieved 2026-11-07)
- [10]
NIDDK says people are more likely to develop type 2 diabetes if they are 45 or older, have a family history of diabetes, are overweight or have obesity, are physically inactive, have prediabetes or had gestational diabetes. confirmedas of 2026-11-07
- Type 2 Diabetes · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · Who is more likely to develop type 2 diabetes? (retrieved 2026-11-07)
- Type 2 Diabetes · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · Who is more likely to develop type 2 diabetes? (retrieved 2026-11-07)
- Type 2 Diabetes · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · Who is more likely to develop type 2 diabetes? (retrieved 2026-11-07)
- [11]
The CDC says more children, teens and young adults are developing type 2 diabetes than in the past. confirmedas of 2026-11-07
- Type 2 Diabetes · Centers for Disease Control and Prevention · Primary source · 2024-05-15 · Key points (cached by fetch-source 2026-11-07) (retrieved 2026-11-07)
- [12]
NIDDK says symptoms of type 2 diabetes often develop slowly over several years and can be so mild they go unnoticed; many people have no symptoms. confirmedas of 2026-11-07
- Type 2 Diabetes · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · Symptoms (retrieved 2026-11-07)
- Type 2 Diabetes · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · Symptoms (retrieved 2026-11-07)
- [13]
NIDDK says some people do not find out they have type 2 diabetes until they develop related problems such as blurred vision or heart disease, and that diabetes is linked to sleep apnea, depression, some cancers and dementia. confirmedas of 2026-11-07
- Type 2 Diabetes · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · Symptoms (retrieved 2026-11-07)
- Type 2 Diabetes · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · What health problems can people with diabetes develop? (retrieved 2026-11-07)
- [14]
The CDC estimates that 115.2 million US adults aged 18 or older have prediabetes. confirmedas of 2026-09-16
- National Diabetes Statistics Report · Centers for Disease Control and Prevention · Primary source · Key figures (label continues "≥18 years with prediabetes"). Cached by fetch-source 2026-11-07 (retrieved 2026-11-07)
- [15]
The American Diabetes Association says diabetes is diagnosed at a two-hour oral glucose tolerance test result of 200 mg/dL or higher (140 to 199 mg/dL is prediabetes), or a random blood glucose of 200 mg/dL or higher in someone with severe symptoms. confirmedas of 2026-11-07
- [16]
The American Diabetes Association says a diagnosis usually needs a test repeated on a second day, carried out in a healthcare setting, unless blood glucose is very high or classic symptoms accompany a positive test. confirmedas of 2026-11-07
- Diagnosis · American Diabetes Association · Primary source · Diagnosis (retrieved 2026-11-07)
- Diagnosis · American Diabetes Association · Primary source · Diagnosis (retrieved 2026-11-07)
- Diabetes Tests & Diagnosis · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · What test results tell me if I have diabetes or prediabetes? (retrieved 2026-11-07)
- [17]
NIDDK says over-the-counter blood glucose meters cannot diagnose diabetes and advises people not to try to diagnose themselves. confirmedas of 2026-11-07
- Diabetes Tests & Diagnosis · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · Diabetes tests and diagnosis (retrieved 2026-11-07)
- [18]
Citing the American Diabetes Association's Standards of Care, NIDDK says adults and children with normal test results should be retested every 3 years and those with prediabetes every year. confirmedas of 2026-11-07
- Diabetes Tests & Diagnosis · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · Who should be tested (retrieved 2026-11-07)
- Diabetes Tests & Diagnosis · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · Who should be tested (retrieved 2026-11-07)
- [19]
NIDDK says managing blood glucose, blood pressure and cholesterol, quitting smoking, healthy meals, limiting calories if overweight and physical activity are important ways to manage type 2 diabetes, along with taking any prescribed medicines. confirmedas of 2026-11-07
- Type 2 Diabetes · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · Managing type 2 diabetes (retrieved 2026-11-07)
- Type 2 Diabetes · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · Managing type 2 diabetes (sentence begins "Managing your blood glucose, blood pressure, and cholesterol") (retrieved 2026-11-07)
- [20]
The NHS says lifestyle changes can sometimes lower blood glucose to a normal level and stop diabetes, which is called remission. confirmedas of 2026-11-07
- Type 2 diabetes - Treatment · NHS (UK National Health Service) · Primary source · Lifestyle changes to help with type 2 diabetes (retrieved 2026-11-07)
- [21]
NIDDK says most people with type 2 diabetes start with metformin, which helps the liver make less glucose and helps the body use insulin better. confirmedas of 2026-11-07
- Insulin, Medicines, & Other Diabetes Treatments · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · Medicines for type 2 diabetes (retrieved 2026-11-07)
- Insulin, Medicines, & Other Diabetes Treatments · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · Medicines for type 2 diabetes (retrieved 2026-11-07)
- [22]
The NHS says people needing medicine for type 2 diabetes who have no other serious conditions are usually offered two medicines, metformin and an SGLT2 inhibitor, which lowers blood sugar by letting extra sugar pass out in urine. confirmedas of 2026-11-07
- Type 2 diabetes - Treatment · NHS (UK National Health Service) · Primary source · Medicines for type 2 diabetes (list continues with metformin and an SGLT2 inhibitor) (retrieved 2026-11-07)
- Type 2 diabetes - Treatment · NHS (UK National Health Service) · Primary source · Medicines for type 2 diabetes (retrieved 2026-11-07)
- [23]
The NHS says people with type 2 diabetes and a history of heart disease may also be offered a GLP-1 agonist, usually injected once a week, as may people living with obesity when other treatments cannot lower blood sugar. confirmedas of 2026-11-07
- Type 2 diabetes - Treatment · NHS (UK National Health Service) · Primary source · Medicines for type 2 diabetes (retrieved 2026-11-07)
- Type 2 diabetes - Treatment · NHS (UK National Health Service) · Primary source · Medicines for type 2 diabetes (retrieved 2026-11-07)
- [24]
In September 2025 WHO added GLP-1 therapies to its Essential Medicines List for type 2 diabetes in high-risk groups. confirmedas of 2025-12-01
- WHO issues global guideline on the use of GLP-1 medicines in treating obesity · World Health Organization · Primary source · 2025-12-01 (retrieved 2026-10-10)
- [25]
NIDDK says people with type 2 diabetes may need more than one diabetes medicine over time, including insulin, and may need insulin at special times such as pregnancy or a hospital stay. confirmedas of 2026-11-07
- Insulin, Medicines, & Other Diabetes Treatments · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · Insulin (retrieved 2026-11-07)
- Type 2 Diabetes · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · What medicines do I need to treat my type 2 diabetes? (retrieved 2026-11-07)
- Type 2 Diabetes · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · What medicines do I need to treat my type 2 diabetes? (retrieved 2026-11-07)
- [26]
In the FLOW trial of 3,533 people with type 2 diabetes and chronic kidney disease, semaglutide lowered the risk of major kidney events or kidney- or cardiovascular-related death by 24% (hazard ratio 0.76); the trial stopped early at a prespecified interim analysis after a median 3.4 years of follow-up. confirmedas of 2024-05-24
- Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) · The New England Journal of Medicine · Primary source · 2024-05-24 · Abstract (retrieved 2026-10-10)
- Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) · The New England Journal of Medicine · Primary source · 2024-05-24 · Abstract (retrieved 2026-10-10)
- [27]
Lilly announced on 28 August 2026 that the FDA approved Mounjaro (tirzepatide) to lower the risk of major adverse cardiovascular events in adults with type 2 diabetes at high risk of them, based on SURPASS-CVOT. confirmedas of 2026-08-28
- FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes · Eli Lilly and Company (press release via PR Newswire) · Primary source · 2026-08-28 (retrieved 2026-10-10)
- FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes · Eli Lilly and Company (press release via PR Newswire) · Primary source · 2026-08-28 (retrieved 2026-10-10)
- [28]
NIDDK says weight-loss (bariatric or metabolic) surgery may help some people with obesity and type 2 diabetes bring blood glucose back to a healthy range, and some no longer need diabetes medicines afterwards. confirmedas of 2026-11-07
- Insulin, Medicines, & Other Diabetes Treatments · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · Weight-loss surgery (retrieved 2026-11-07)
- Insulin, Medicines, & Other Diabetes Treatments · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · Weight-loss surgery (retrieved 2026-11-07)
- [29]
The Diabetes Prevention Program randomised 3,234 people without diabetes but with raised fasting and post-load glucose to placebo, metformin or a lifestyle programme aiming for at least 7% weight loss and at least 150 minutes of physical activity a week; it ran at 27 US centres from 1996 to 2001. confirmedas of 2026-11-07
- Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin (NEJM 2002; PubMed abstract) · New England Journal of Medicine (via NCBI PubMed) · Primary source · 2002-02-07 · Abstract, Methods (retrieved 2026-11-07)
- Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin (NEJM 2002; PubMed abstract) · New England Journal of Medicine (via NCBI PubMed) · Primary source · 2002-02-07 · Abstract, Methods (retrieved 2026-11-07)
- Diabetes Prevention Program (DPP) · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · DPP study design (retrieved 2026-11-07)
- [30]
In the DPP, 6.9 people would need to take part in the lifestyle programme, or 13.9 take metformin, to prevent one case of diabetes over three years. confirmedas of 2026-11-07
- Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin (NEJM 2002; PubMed abstract) · New England Journal of Medicine (via NCBI PubMed) · Primary source · 2002-02-07 · Abstract, Results (retrieved 2026-11-07)
- [31]
NIDDK reports the DPP lifestyle programme worked for all racial and ethnic groups studied and for men and women, and lowered the chance of type 2 diabetes by 71% in participants aged 60 and older. confirmedas of 2026-11-07
- Diabetes Prevention Program (DPP) · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · DPP results (retrieved 2026-11-07)
- Diabetes Prevention Program (DPP) · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · DPP results (retrieved 2026-11-07)
- [32]
NIDDK reports that the DPP Outcomes Study found lifestyle and metformin participants continued to prevent or delay type 2 diabetes for at least 15 years; at 15 years the lifestyle group's diabetes onset was 27% lower than placebo. confirmedas of 2026-11-07
- Diabetes Prevention Program (DPP) · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · DPPOS overview (retrieved 2026-11-07)
- Diabetes Prevention Program (DPP) · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · DPPOS 15-year results (retrieved 2026-11-07)
- [33]
Citing the DPP Outcomes Study, NIDDK says people at risk may be able to prevent or delay type 2 diabetes by losing 5% to 7% of their weight, and suggests at least 30 minutes of physical activity at least 5 days a week. confirmedas of 2026-11-07
- Type 2 Diabetes · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · How can I lower my chances of developing type 2 diabetes? (retrieved 2026-11-07)
- Type 2 Diabetes · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · How can I lower my chances of developing type 2 diabetes? (retrieved 2026-11-07)
- [34]
NIDDK says a group version of the DPP lifestyle programme tested in YMCAs is widely available in the US through the CDC's National Diabetes Prevention Program, which Medicare began covering in 2018. confirmedas of 2026-11-07
- Diabetes Prevention Program (DPP) · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · Translating the DPP (retrieved 2026-11-07)
- Diabetes Prevention Program (DPP) · National Institute of Diabetes and Digestive and Kidney Diseases (NIH) · Primary source · Translating the DPP (sentence continues "Program") (retrieved 2026-11-07)
Revision history (1)
- Page created.
Created Nov 7, 2026. Last reviewed by an editor on Nov 8, 2026. Next scheduled review: Jan 15, 2027.
Cite this page
"Type 2 diabetes explained: diagnosis, treatment and prevention." ContentLora, updated Nov 7, 2026. https://contentlora.com/explain/type-2-diabetes-explained
Spotted an error? Suggest a correction or emailcorrections@contentlora.com.